West Pharmaceutical Services, Inc. (WST)
364.98
-0.03
(-0.01%)
USD |
NYSE |
Oct 02, 16:00
364.75
-0.23
(-0.06%)
Pre-Market: 20:00
West Pharmaceutical Services Gross Profit Margin (Quarterly) : 37.83% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.83% |
| March 31, 2026 | 35.11% |
| December 31, 2025 | 37.85% |
| September 30, 2025 | 36.49% |
| June 30, 2025 | 35.66% |
| March 31, 2025 | 33.33% |
| December 31, 2024 | 36.66% |
| September 30, 2024 | 35.51% |
| June 30, 2024 | 32.95% |
| March 31, 2024 | 33.27% |
| December 31, 2023 | 38.11% |
| September 30, 2023 | 38.73% |
| June 30, 2023 | 38.74% |
| March 31, 2023 | 37.80% |
| December 31, 2022 | 37.18% |
| September 30, 2022 | 38.97% |
| June 30, 2022 | 41.45% |
| March 31, 2022 | 39.57% |
| December 31, 2021 | 40.14% |
| September 30, 2021 | 40.83% |
| June 30, 2021 | 43.70% |
| March 31, 2021 | 40.64% |
| December 31, 2020 | 36.45% |
| September 30, 2020 | 34.82% |
| June 30, 2020 | 36.91% |
| Date | Value |
|---|---|
| March 31, 2020 | 33.99% |
| December 31, 2019 | 33.17% |
| September 30, 2019 | 32.32% |
| June 30, 2019 | 33.55% |
| March 31, 2019 | 33.05% |
| December 31, 2018 | 31.47% |
| September 30, 2018 | 31.39% |
| June 30, 2018 | 31.84% |
| March 31, 2018 | 32.51% |
| December 31, 2017 | 31.11% |
| September 30, 2017 | 31.56% |
| June 30, 2017 | 31.50% |
| March 31, 2017 | 34.63% |
| December 31, 2016 | 32.21% |
| September 30, 2016 | 32.15% |
| June 30, 2016 | 34.30% |
| March 31, 2016 | 34.08% |
| December 31, 2015 | 33.12% |
| September 30, 2015 | 31.27% |
| June 30, 2015 | 32.65% |
| March 31, 2015 | 32.48% |
| December 31, 2014 | 31.45% |
| September 30, 2014 | 30.82% |
| June 30, 2014 | 33.02% |
| March 31, 2014 | 30.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Globus Medical, Inc. | 65.92% |
| Veracyte, Inc. | 71.93% |
| Hinge Health, Inc. | 86.44% |
| The Cooper Cos., Inc. | 62.36% |
| Repligen Corp. | 49.25% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.66% |
| Return on Assets | 13.77% |
| Return on Invested Capital | 16.90% |
| Profit Margin (Quarterly) | 17.65% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | 18.60% |